Overview

The Gene Technology Act 2000 was enacted by the Commonwealth Parliament to provide a regulatory framework for the development and use of gene technology in Australia, ensuring that risks to human health and the environment are properly identified and managed. The Act aims to strike a balance between fostering innovation and ensuring public safety. The Gene Technology Regulator, as part of the Office of the Gene Technology Regulator, is responsible for assessing applications and determining whether to issue licences for activities involving genetically modified organisms. The policy objective of the Act is to protect human health and the environment while facilitating the responsible use of gene technology. The Act was introduced to address the need for a coherent and robust regulatory system to oversee the development and use of genetically modified organisms, particularly in light of growing concerns about the potential risks associated with such technology.

Scope and Application

The legislation in question, C2014G01872, pertains to a field trial of genetically modified (GM) safflower in Australia, overseen by the Gene Technology Regulator. The Act applies specifically to the proposed limited and controlled release of GM safflower, engineered for high oleic acid composition, to be conducted by the Commonwealth Scientific and Industrial Research Organisation (CSIRO). The primary focus of this field trial is to assess the oil content and agronomic performance of the GM safflower under various field conditions across multiple Australian states, including Queensland, Victoria, New South Wales, the Australian Capital Territory, and Western Australia. The trial is geographically bound to these regions and is scheduled to run from January 2015 to August 2019, with a maximum cumulative planting area of 850 hectares. Notably, the GM safflower is not intended for use in human food or animal feed, thereby limiting its application strictly to industrial processes and research purposes. The Act does not explicitly mention any exclusions, exemptions, or thresholds, but it does outline a Risk Assessment and Risk Management Plan (RARMP) to mitigate any potential risks to human health and the environment, which will form the basis of the decision on whether to issue the licence. The Regulator is inviting submissions to finalise the RARMP, welcoming public input to ensure a comprehensive risk evaluation.

Key Provisions

The legislation (C2014G01872) outlines the assessment and proposed field trial of genetically modified (GM) safflower by CSIRO, which is subject to review by the Gene Technology Regulator (section 1). The main purpose of the trial, as stated in section 2, is to evaluate the oil content and agronomic performance of the GM safflower under field conditions across various regions in Australia and to provide extracted oil for product development and testing in industrial processes. The trial is proposed to occur at 45 sites in Queensland, Victoria, New South Wales, ACT, and Western Australia from January 2015 to August 2019, with a maximum cumulative planting area of 850 hectares over the 4 years. Importantly, the GM safflower would not be used in human food or animal feed (section 3). Section 4 of the legislation details the obligations and requirements imposed by the Act. The Gene Technology Regulator is tasked with assessing the Licence Application DIR 131 from CSIRO, ensuring that all proposed activities comply with the Act’s provisions to protect human health and the environment. The Regulator must evaluate the Risk Assessment and Risk Management Plan (RARMP) prepared by CSIRO, which includes an assessment of potential risks and measures to manage those risks. The RARMP, as detailed in section 5, concludes that the proposed release would pose negligible risk to human health and safety or to the environment. Section 6 outlines the potential consequences for breach of the Act. While the specific offences, penalties, or civil/criminal consequences for breach are not detailed in the provided text, it is implied that any non-compliance with the Act or the imposed licence conditions could result in enforcement actions by the Regulator. The Act generally provides for enforcement measures, including fines and other penalties, to ensure adherence to its provisions. The specific penalties would depend on the nature and severity of the breach, and could potentially include substantial fines as stipulated under the Gene Technology Act 2000. In summary, the legislation primarily focuses on the regulatory framework for assessing and approving the field trial of GM safflower by CSIRO, with an emphasis on protecting human health and the environment. The Regulator’s role is to ensure that the trial complies with the necessary safety and environmental standards, and any failure to adhere to the Act’s requirements could lead to enforcement actions and penalties.